| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935158 | Schizophrenia Research | 2016 | 5 Pages |
Abstract
In conclusion, cannabis use is likely to be associated with a lower BMI in patients with a psychotic disorder. Moreover, AKT1 risk alleles may increase the incidence of cannabis use in patients with a psychotic disorder, but AKT1 does not appear to mediate the effect of cannabis on BMI.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Edith J. Liemburg, Jojanneke Bruins, Nico van Beveren, Md. Atiqul Islam, Behrooz Z. Alizadeh,